FDA Inspection 1261728 - Braintree, A part of SEBELA Pharmaceuticals - March 07, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Braintree, A part of SEBELA Pharmaceuticals, with an inspection on March 7, 2025, issued by the New England District Office, covering human drugs.

Company: Braintree, A part of SEBELA Pharmaceuticals
Inspection Date: March 7, 2025
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 2f230059-8323-442e-8b68-dd71d065676a